Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancer

NCT05070026 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT05070026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05070026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancer
Lead sponsor
Shengjing Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2021
Completion date
December 31, 2021
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory reaction, life scores, video-assisted thoracoscopic surgery